Cargando…
Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor
Type 1 diabetes (T1D) is an autoimmune disease that selectively destroys insulin-producing β-cells in the pancreas. An unmet need in diabetes management, current therapy is focussed on transplantation. While the reprogramming of progenitor cells into functional insulin-producing β-cells has also bee...
Autores principales: | Al-Hasani, Keith, Khurana, Ishant, Mariana, Lina, Loudovaris, Thomas, Maxwell, Scott, Harikrishnan, K. N., Okabe, Jun, Cooper, Mark E., El-Osta, Assam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304326/ https://www.ncbi.nlm.nih.gov/pubmed/35864094 http://dx.doi.org/10.1038/s41392-022-01034-7 |
Ejemplares similares
-
Pharmacological inhibition of human EZH2 can influence a regenerative β-like cell capacity with in vitro insulin release in pancreatic ductal cells
por: Naina Marikar, Safiya, et al.
Publicado: (2023) -
Epigenetic evidence of an Ac/Dc axis by VPA and SAHA
por: Lunke, Sebastian, et al.
Publicado: (2021) -
DNA methylation status correlates with adult β-cell regeneration capacity
por: Khurana, Ishant, et al.
Publicado: (2021) -
SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis
por: Khurana, Ishant, et al.
Publicado: (2021) -
Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways
por: Felisbino, Marina Barreto, et al.
Publicado: (2021)